Basit öğe kaydını göster

Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity

dc.contributor.authorSpelman, T.
dc.contributor.authorIzquierdo, G.
dc.contributor.authorAlroughani, R.
dc.contributor.authorFernandez Bolaos, R.
dc.contributor.authorHavrdova, E.
dc.contributor.authorHoraova, D.
dc.contributor.authorButzkueven, H.
dc.date.accessioned2020-06-21T13:45:28Z
dc.date.available2020-06-21T13:45:28Z
dc.date.issued2015
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14089
dc.description31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- OCT 07-10, 2015 -- Barcelona, SPAINen_US
dc.descriptionLugaresi, Alessandra/0000-0003-2902-5589; Slee, Mark/0000-0003-4323-2453; Oreja-Guevara, Celia/0000-0002-9221-5716; Havrdova, Eva Kubala/0000-0002-9543-4359en_US
dc.descriptionWOS: 000365729400421en_US
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosisen_US
dc.language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activityen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume21en_US
dc.identifier.startpage237en_US
dc.identifier.endpage238en_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster